An approach to analysis of large-scale correlations between genome changes and clinical endpoints in ovarian cancer.
Data up to Jan 2025
Total Citations Per Year
Abstract
References (18)
Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian Cancer
1989 • 6,734 citations
Comparative Genomic Hybridization for Molecular Cytogenetic Analysis of Solid Tumors
1992 • 3,344 citations
PIK3CA is implicated as an oncogene in ovarian cancer
1999 • 1,170 citations
Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas
1995 • 831 citations
Overexpression and mutation of p53 in epithelial ovarian cancer.
1991 • 464 citations
Genetic analysis of benign, low-grade, and high-grade ovarian tumors.
1995 • 299 citations
NOEY2 (ARHI), an imprinted putative tumor suppressor gene in ovarian and breast carcinomas
1999 • 298 citations
Mutations of the E–cadherin gene in human gynecologic cancers
1994 • 280 citations
Spectrum of Mutation and Frequency of Allelic Deletion of the p53 Gene in Ovarian Cancer
1993 • 184 citations
Molecular Cloning of Differentially Expressed Genes in Human Epithelial Ovarian Cancer
1994 • 183 citations
Mutation of the Ki-ras protooncogene in human endometrial hyperplasia and carcinoma.
1993 • 176 citations
Identification of two candidate tumor suppressor genes on chromosome 17p13.3.
1996 • 146 citations
SPARC, an extracellular matrix protein with tumor-suppressing activity in human ovarian epithelial cells.
1996 • 135 citations
c-myc amplification in ovarian cancer
1990 • 127 citations
Identification of a gene containing zinc-finger motifs based on lost expression in malignantly transformed rat ovarian surface epithelial cells.
1997 • 118 citations
Comparison of loss of heterozygosity patterns in invasive low-grade and high-grade epithelial ovarian carcinomas.
1993 • 97 citations
Loss of heterozygosity on chromosome 5q in ovarian cancer is frequently accompanied by TP53 mutation and identifies a tumour suppressor gene locus at 5q13.1-21
1996 • 52 citations
First experience with FGF-3 (INT-2) amplification in women with epithelial ovarian cancer
1993 • 29 citations